Tsuchiya H, Ueda Y, Morishita H, Nonomura A, Kawashima A, Fellinger E J, Tomita K
Department of Orthopaedic Surgery, School of Medicine, Kanazawa University, Ishikawa, Japan.
J Cancer Res Clin Oncol. 1993;119(6):363-8. doi: 10.1007/BF01208847.
We reviewed histological and clinical findings of six cases of borderline chondrosarcoma and examined the expression of collagen types I, II, III, V, and VI by immunohistochemical analysis of these tumors. Borderline chondrosarcoma is defined as a cartilaginous tumor of bone resembling enchondroma on the basis of histomorphology. Clinically the tumor causes intermittent vague pain unrelated to physical activities. On radiographs borderline chondrosarcoma is characterized by evidence of endosteal erosion. We observed local recurrences in two cases treated by intralesional excision and marginal excision, and one of those cases died of inoperable local tumor recurrence. In our histological analysis based on tissue patterns, there were enchondromatous patterns in five cases, and chondrosarcomatous patterns in four cases. In the second recurrent tumor in one case, a chondrosarcomatous pattern was newly observed, and the recurrent tumor was found to be a low-grade chondrosarcoma cytologically in the other case. In the tumor matrix immunoreactivity for collagen types II and VI was predominant, with collagen types I, III, and V showing heterogeneous expression in some cases. In all cases rimming of tumor lobules with collagen types I and V was absent. Immunoreactivity for collagen type II in the cytoplasm of tumor cells was found in four cases and all three recurrent tumors. Borderline chondrosarcoma, as defined by histology, clinical symptoms and radiological appearance, shows a collagen distribution pattern similar to that of low-grade chondrosarcoma. These findings are in accordance with the clinical outcome of borderline chondrosarcoma which parallels that of low-grade chondrosarcoma. Thus borderline chondrosarcoma may be best treated by wide en-bloc excision rather than curettage.
我们回顾了6例交界性软骨肉瘤的组织学和临床发现,并通过对这些肿瘤进行免疫组织化学分析,检测了I、II、III、V和VI型胶原蛋白的表达。交界性软骨肉瘤在组织形态学上被定义为一种类似于内生软骨瘤的骨软骨肿瘤。临床上,该肿瘤引起与体力活动无关的间歇性隐痛。在X线片上,交界性软骨肉瘤的特征是有骨内膜侵蚀的证据。我们观察到2例接受病灶内切除和边缘切除治疗的患者出现局部复发,其中1例死于无法手术切除的局部肿瘤复发。在我们基于组织模式的组织学分析中,5例有内生软骨瘤样模式,4例有软骨肉瘤样模式。在1例患者的第二次复发肿瘤中,新观察到软骨肉瘤样模式,在另一例中,复发肿瘤在细胞学上被发现为低级别软骨肉瘤。在肿瘤基质中,II型和VI型胶原蛋白的免疫反应性占主导,I、III和V型胶原蛋白在某些情况下表现出异质性表达。在所有病例中,肿瘤小叶均未出现I型和V型胶原蛋白包绕。在4例病例及所有3例复发肿瘤中,均在肿瘤细胞胞质中发现了II型胶原蛋白的免疫反应性。根据组织学、临床症状和放射学表现定义的交界性软骨肉瘤,其胶原蛋白分布模式与低级别软骨肉瘤相似。这些发现与交界性软骨肉瘤与低级别软骨肉瘤相似的临床结果一致。因此,交界性软骨肉瘤最好采用广泛整块切除而非刮除术进行治疗。